Unique 5-year collaboration and extensive IP licensing agreement

Unique 5-year collaboration and extensive IP licensing agreement

ReWalk just announced its agreement with the Wyss Institute at Harvard University for collaboration on the development of "Soft Suit" exoskeleton systems for the treatment of stroke, Multiple Sclerosis and limited mobility patients.

Dept of VA Affairs purchases 20 ReWalk Systems

Friday, May 6, equities.com reported that the VA purchased an additional 20 ReWalk Personal Systems to support initiation of their national multi-center clinical trial.